← board
BUDZ
distress 6/10 · elevated risk$0.02-33%today-71% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.0 yrs
Shares 1y
+9%
Price & events
-50.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
-33.3%
1D
-33.3%
1W
+0.0%
1M
-50.0%
3M
-50.0%
6M
-33.3%
1Y
-71.4%
2Y
-94.1%
5Y
-90.9%
All
Overview
- Market Cap
- $2.97M
- Volume
- 28.70K
- 52 Week Range
- $0.02 – $0.07
- Total Shares
- 148.31M
- Float Shares
- 60.12M
- % Held by Insiders
- 59.47%
- % Held by Institutions
- 0.00%
- RVOL
- 1.11x
- Beta
- 1.40
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 148,312,685 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.